Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Beissert

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
COVID-19 and immune checkpoint inhibitorsM S Ahmed, H Brehme, S Friedrich, et al.
European Journal of Public Health|June 16, 2007
Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological settingP Hensen, S Beissert, L Bruckner-Tuderman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2019
Medical treatment of advanced cutaneous squamous-cell carcinomaF F Gellrich, S Hüning, S Beissert, et al.
The Journal of Investigative Dermatology|October 9, 1998
Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1betaS Beissert, J Hosoi, A Stratigos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced toleranceA Schwarz, S Beissert, K Grosse-Heitmeyer, et al.
The Journal of Experimental Medicine|September 6, 2001
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunityA Mehling, K Loser, G Varga, et al.
European Journal of Microbiology & Immunology|February 12, 2014
In vitro induced CD8+ regulatory T cells inhibit skin inflammationD Fleissner, K Loser, W Hansen, et al.
Cancer Research|April 28, 2001
Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesisH Rossiter, S Beissert, C Mayer, et al.
The Journal of Investigative Dermatology|July 8, 2000
Tumor antigen presentation by dermal antigen-presenting cellsK Campton, W Ding, Z Yan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2011
Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphomaA C Hüsken, A Tsianakas, P Hensen, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
COVID-19 and immune checkpoint inhibitorsM S Ahmed, H Brehme, S Friedrich, et al.
European Journal of Public Health|June 16, 2007
Introduction of diagnosis-related groups in Germany: evaluation of impact on in-patient care in a dermatological settingP Hensen, S Beissert, L Bruckner-Tuderman, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 14, 2019
Medical treatment of advanced cutaneous squamous-cell carcinomaF F Gellrich, S Hüning, S Beissert, et al.
The Journal of Investigative Dermatology|October 9, 1998
Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1betaS Beissert, J Hosoi, A Stratigos, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2000
Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced toleranceA Schwarz, S Beissert, K Grosse-Heitmeyer, et al.
The Journal of Experimental Medicine|September 6, 2001
Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunityA Mehling, K Loser, G Varga, et al.
European Journal of Microbiology & Immunology|February 12, 2014
In vitro induced CD8+ regulatory T cells inhibit skin inflammationD Fleissner, K Loser, W Hansen, et al.
Cancer Research|April 28, 2001
Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesisH Rossiter, S Beissert, C Mayer, et al.
The Journal of Investigative Dermatology|July 8, 2000
Tumor antigen presentation by dermal antigen-presenting cellsK Campton, W Ding, Z Yan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2011
Comparison of pegylated interferon α-2b plus psoralen PUVA versus standard interferon α-2a plus PUVA in patients with cutaneous T-cell lymphomaA C Hüsken, A Tsianakas, P Hensen, et al.
Pageof 7